Acetic acid, the active component of vinegar, is an effective tuberculocidal disinfectant

mBio

Volumn 5, Issue 2, 2014, Pages

  Cortesia, Claudia ^a   Vilchèze, Catherine ^b   Bernut, Audrey ^c   Contreras, Whendy ^a   Gómez, Keyla ^d   de Waard, Jacobus ^d   Jacobs Jr , William R ^b   Kremer, Laurent ^c,e   Takiff, Howard ^a  

^a Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIV MONTPELLIER   (France)

^d INSTITUTO DE BIOMEDICINA   (Venezuela)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; PROPIONIC ACID; VINEGAR;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOSAFETY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISINFECTION; EXPOSURE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM BOLLETII; MYCOBACTERIUM MASSILIENSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACID; ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; DISINFECTANTS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PROPIONATES; TIME FACTORS;

EID: 84899741838     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00013-14     Document Type: Article

References (27)

1. Esteban J, García-Pedrazuela M, Muñoz-Egea MC, Alcaide F. 2012. Current treatment of nontuberculous mycobacteriosis: an update. Expert Opin. Pharmacother. 13:967-986. http://dx.doi.org/10.1517/ 14656566.2012.677824.
2. Chan ED, Bai X, Kartalija M, Orme IM, Ordway DJ. 2010. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. Am. J. Respir. Cell Mol. Biol. 43:387-393. http:// dx.doi.org/10.1165/rcmb.2009-0276TR.
3. Daley CL, Caminero JA. 2013. Management of multidrug resistant tuberculosis. Semin. Respir. Crit. Care Med. 34:44-59. http://dx.doi.org/ 10.1055/s-0032-1333546.
4. McDonnell G, Russell AD. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179.
5. Cortesia C, Lopez GJ, de Waard JH, Takiff HE. 2010. The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections. J. Antimicrob. Chemother. 65:2574-2581. http://dx.doi.org/10.1093/jac/dkq366.
6. Mazzola PG, Penna TC, Martins AM. 2003. Determination of decimal reduction time (D value) of chemical agents used in hospitals for disinfection purposes. BMC Infect. Dis. 3:24. http://dx.doi.org/10.1186/1471-2334-3-24.
7. Shang S, Gibbs S, Henao-Tamayo M, Shanley CA, McDonnell G, Duarte RS, Ordway DJ, Jackson M. 2011. Increased virulence of an epidemic strain of Mycobacterium massiliense in mice. PLoS One 6:e24726. http://dx.doi.org/10.1371/journal.pone.0024726.
8. Blancou J. 1995. History of disinfection from early times until the end of the 18th century. Rev. Sci. Tech. 14:21-39.
9. Johnston CS, Gaas CA. 2006. Vinegar: medicinal uses and antiglycemic effect. MedGenMed 8:61.
10. Entani E, Asai M, Tsujihata S, Tsukamoto Y, Ohta M. 1998. Antibacterial action of vinegar against food-borne pathogenic bacteria including Escherichia coli O157:H7. J. Food Prot. 61:953-959.
11. Vijayakumar C, Wolf-Hall CE. 2002. Evaluation of household sanitizers for reducing levels of Escherichia coli on iceberg lettuce. J. Food Prot. 65:1646-1650.
12. Kaushik V, Malik T, Saeed SR. 2010. Interventions for acute otitis externa. Cochrane Database Syst. Rev. 1:CD004740. http://dx.doi.org/ 10.1002/14651858.CD004740.pub2.
13. Benassati HE, Marfil LM, Occhionero M. 1994. Acido Acético. Su capacidad disinfectante. Acta Bioquímica Clín. Latinoam. XXVII:411-419.
14. Gumbo T, Dona CS, Meek C, Leff R. 2009. Pharmacokineticspharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs. Antimicrob. Agents Chemother. 53:3197-3204. http:// dx.doi.org/10.1128/AAC.01681-08.
15. Sung N, Collins MT. 2003. Variation in resistance of Mycobacterium paratuberculosis to acid environments as a function of culture medium. Appl. Environ. Microbiol. 69:6833-6840. http://dx.doi.org/10.1128/ AEM.69.11.6833-6840.2003.
16. Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR, Jr. 2006. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24: 6309-6320. http://dx.doi.org/10.1016/j.vaccine.2006.05.097.
17. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. 2012. Mycobacterium abscessus: a new antibiotic nightmare. J. Antimicrob. Chemother. 67:810-818. http://dx.doi.org/10.1093/jac/dkr578.
18. Anonymous. 1997. Chemical disinfectants and antiseptics-basic bactericidal activity-test method and requirement (phase 1). EN-1040. Nederlands Normalistatie-Instituut, Delft, The Netherlands.
19. Health Canada. 27 April 2010. Release of frequently asked questions related to Health Canada's Guidance Document: disinfectant drugs. Health Canada, Ottawa, Ontario, Canada.
20. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. 2008. Guideline for disinfection and sterilization in health care facilities, 2008. CDC, Atlanta, GA.
21. Harvey CJ, LeBouf RF, Stefaniak AB. 2010. Formulation and stability of a novel artificial human sweat under conditions of storage and use. Toxicol. In Vitro 24:1790-1796. http://dx.doi.org/10.1016/j.tiv.2010.06.016.
22. Reid JD. 1932. The disinfectant action of certain organic acids. Am. J. Hyg. 16:540-556.
23. Barker RM. 1964. The bactericidal action of low molecular weight compounds. J. Appl. Bacteriol. 27:213-220. http://dx.doi.org/10.1111/j.1365-2672.1964.tb04905.x.
24. Taylor K. 1916. Treatment of Bacillus pyocyaneus infection. JAMA 67: 1598-1599.
25. Taylor K. 1917. Specificity in antiseptics. Lancet 189:294-297. http:// dx.doi.org/10.1016/S0140-6736(01)48011-1.
26. Walsh DS, Portaels F, Meyers WM. 2010. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection). Curr. Opin. Infect. Dis. 23:445-455. http://dx.doi.org/10.1097/QCO.0b013e32833c2209.
27. Nagoba BS, Deshmukh SR, Wadher BJ, Mahabaleshwar L, Gandhi RC, Kulkarni PB, Mane VA, Deshmukh JS. 1998. Treatment of superficial pseudomonal infections with citric acid: an effective and economical approach. J. Hosp. Infect. 40:155-157. http://dx.doi.org/10.1016/S0195-6701(98)90188-8.